This suggests that EBV infection may inhibit differentiation and interfere with HER-2 expression through specific molecular pathways such as Latent Membrane Protein 1/2A (LMP1/2A)-mediated oncogenic signaling (3). The gene discussed is ERBB2; the disease is Epstein-Barr virus infection.